3-benzylthiazolin-2-thione | 111427-04-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-benzylthiazolin-2-thione
• 英文别名: 3-benzyl-4,5-dimethyl-3H-thiazole-2-thione；3-Benzyl-4,5-dimethyl-3H-thiazol-2-thion；3-Benzyl-4,5-dimethyl-1,3-thiazole-2-thione
• CAS: 111427-04-4
• 化学式: C₁₂H₁₃NS₂
• 分子量: 235.374
• InChiKey: BMXYJGAXHMDLSD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  60.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-benzylthiazolin-2-thione 在 氨 、 硫酸二甲酯 作用下， 以 乙醇 为溶剂， 以91%的产率得到3-benzyl-4,5-dimethyl-1,3-thiazol-2(3H)-imine
  参考文献：
  名称：

  Carbene versus Dimer Formation from Diazo Derivatives: The Anomalous Behaviour of 2-Diazothiazolines

  摘要：

  DOI：

  10.3987/r-1986-11-3097
• 作为产物：
  描述：

  3-benzyl-4-methyl-5-methylene-thiazolidine-2-thione 在 硫酸 作用下， 生成 3-benzylthiazolin-2-thione
  参考文献：
  名称：

  168.乙炔反应。第三部分 氨基丁炔与二硫化碳的反应

  摘要：

  DOI：

  10.1039/jr9490000786

文献信息

• CASTELLS J.; CAHAHORRA F. L.; GAIJO F., HETEROCYCLES, 24,(1986) N 11, 3097-3104
  作者：CASTELLS J.、 CAHAHORRA F. L.、 GAIJO F.

  DOI：——

  日期：——
• IDO INHIBITORS
  申请人：Newlink Genetics

  公开号：EP2227233A2

  公开（公告）日：2010-09-15
• [EN] IDO INHIBITORS<br/>[FR] INHIBITEURS DE L'IDO
  申请人：NEWLINK GENETICS

  公开号：WO2009073620A2

  公开（公告）日：2009-06-11

  Presently provided are methods for (a) modulating an activity of indoleamine 2,3-dioxygenase comprising contacting an indoleamine 2,3-dioxygenase with a modulation effective amount of a compound as described in one of the aspects described herein; (b) treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression in a subject in need thereof, comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount of a compound as described in one of the aspects described herein; (c) treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount of a compound as described in one of the aspects described herein; (d) enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent and a compound as described in one of the aspects described herein; (e) treating tumor-specific immunosuppression associated with cancer comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount of a compound as described in one of the aspects described herein; and (f) treating immunosuppression associated with an infectious disease, e.g., HIV-I infection, comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount a compound as described in one of the aspects described herein.
• 168. Acetylene reactions. Part III. Reaction of aminobutynes with carbon disulphide
  作者：J. W. Batty、B. C. L. Weedon

  DOI：10.1039/jr9490000786

  日期：——
• Carbene versus Dimer Formation from Diazo Derivatives: The Anomalous Behaviour of 2-Diazothiazolines
  作者：Josep Castells、Francisco L用ez Calahorra、Fernando Geijo

  DOI：10.3987/r-1986-11-3097

  日期：——